| 000 | 01666 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515095647.0 | ||
| 264 | 0 | _c20080626 | |
| 008 | 200806s 0 0 eng d | ||
| 022 | _a1476-5551 | ||
| 024 | 7 |
_a10.1038/sj.leu.2405054 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAtallah, E | |
| 245 | 0 | 0 |
_aPrognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis. _h[electronic resource] |
| 260 |
_bLeukemia _cJun 2008 |
||
| 300 |
_a1295-8 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnemia, Refractory _xclassification |
| 650 | 0 | 4 |
_aAnemia, Sideroblastic _xclassification |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJanus Kinase 2 _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xclassification |
| 650 | 0 | 4 |
_aMyeloproliferative Disorders _xclassification |
| 650 | 0 | 4 |
_aPoint Mutation _xgenetics |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aThrombocytosis _xclassification |
| 650 | 0 | 4 | _aWorld Health Organization |
| 700 | 1 | _aNussenzveig, R | |
| 700 | 1 | _aYin, C C | |
| 700 | 1 | _aBueso-Ramos, C | |
| 700 | 1 | _aTam, C | |
| 700 | 1 | _aManshouri, T | |
| 700 | 1 | _aPierce, S | |
| 700 | 1 | _aKantarjian, H | |
| 700 | 1 | _aVerstovsek, S | |
| 773 | 0 |
_tLeukemia _gvol. 22 _gno. 6 _gp. 1295-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.leu.2405054 _zAvailable from publisher's website |
| 999 |
_c17573668 _d17573668 |
||